Design, synthesis and biological evaluation of 4-methoxy diaryl isophthalates as antiplatelet agents

被引:1
作者
Liu Xiu-jie [1 ,2 ]
Wang Chao-qing [1 ,2 ]
Meng Jie [1 ]
Shi Xin-xin [1 ]
Yan Ya-nan [1 ]
Liu Xu-guang [1 ]
机构
[1] Tianjin Univ Technol, Coll Chem & Chem Engn, Tianjin 300384, Peoples R China
[2] Tianjin Univ Technol, Tianjin Key Lab Organ Solar Cells & Photochem Con, Sch Chem & Chem Engn, Tianjin 300384, Peoples R China
基金
美国国家科学基金会;
关键词
4-Methoxy diphenyl isophthalates; Antiplatelet aggregation; SAR; Organic synthesis; IN-VITRO ACTIVITIES; PLATELET-AGGREGATION; DERIVATIVES; PICOTAMIDE; INHIBITION;
D O I
10.1007/s00044-017-2075-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 4-methoxy diphenyl isophthalates, which are the isosturctural analogs of picotamide, were designed and synthesized using the concept of isosterism. The structures of these new analogs were characterized by all means of spectroscopy, including 1H NMR, 13C NMR, and MS spectra. In vitro antiplatelet aggregation activities of these compounds were investigated by using Born's test method. Among the 19 compounds tested for both ADP and collagen inducers, six of them (P216-P219 and P220-P221) were found to exhibit higher activity in vitro antiplatelet aggregation than Picotamide. In particular, the compound P220 bearing a nitrooxyl group showed the highest acitivity 72.1% (induced by collagen) and 72.5% (induced by ADP), with IC50 values of 0.30 mu M/L induced by ADP (1.3 mu M/L) and LD50 > 2500 mg/kg, could have dual mechanism of action. Evaluation of cytotoxic activity of the compounds against L929 cell line revealed that none of the compounds have significant cytotoxicity. Through the careful analysis of in vitro activity data, the SAR of these compounds was preliminarily deduced. The results of this study showed that 4-methoxy diaryl isophthalates derivatives are potential to become an antiplatelet aggregation agents.
引用
收藏
页码:488 / 496
页数:9
相关论文
共 23 条
[1]  
Abe S, 2000, J Infect Chemother, V6, P35, DOI 10.1007/s101560050047
[2]   Clinical evidence for lead-induced inhibition of nitric oxide formation [J].
Barbosa, Fernando, Jr. ;
Sertorio, Jonas T. C. ;
Gerlach, Raquel F. ;
Tanus-Santos, Jose E. .
ARCHIVES OF TOXICOLOGY, 2006, 80 (12) :811-816
[3]   AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE AND ITS REVERSAL [J].
BORN, GVR .
NATURE, 1962, 194 (4832) :927-&
[4]   Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition [J].
Brito, Fernanda C. F. ;
Kummerle, Arthur E. ;
Lugnier, Claire ;
Fraga, Carlos A. M. ;
Barreiro, Eliezer J. ;
Miranda, Ana L. P. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 638 (1-3) :5-12
[5]   Neuraxial anesthesia in obstetric patients receiving anticoagulant and antithrombotic drugs [J].
Butwick, A. J. ;
Carvalho, B. .
INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 2010, 19 (02) :193-201
[6]  
Celestini A, 2007, VASC HEALTH RISK MAN, V3, P93
[7]  
Cirino Giuseppe, 2006, Inflammation & Allergy Drug Targets, V5, P115, DOI 10.2174/187152806776383143
[8]  
Ellis James L., 2005, Inflammopharmacology, V12, P521
[9]  
GRESELE P, 1989, THROMB HAEMOSTASIS, V61, P479
[10]  
Li Gui-liang, 2015, Yaoxue Xuebao, V50, P185